Global Alzheimer Disease Patients Market & Drugs Analysis 2015 Forecasts Now Available at - WDRB 41 Louisville News

Global Alzheimer Disease Patients Market & Drugs Analysis 2015 Forecasts Now Available at


This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: adds "Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis" report to its research store.

Dallas, Texas (PRWEB) July 02, 2014

Alzheimers is a complex disease and there is no single magic bullet available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimers disease, it still remains a significant area of unmet medical need. Clinical success has proven elusive; however, numerous companies are developing novel treatments. Currently theres no cure for Alzheimers and its still waiting for its key product. In addition, all current marketed products are going to be generic in the next five years.

In 2010, there were more than 30 Million people suffering with Alzheimers disease but it is anticipated that by 2015 over 35 Million people worldwide will be suffering from this disease. Much of this increase will be due to increase in number of people with Alzheimers in low and middle income countries. Since the risk of getting the disease increases with age, the number of patients with the illness to be found in any community will depend on the proportion of older people in the group. Traditionally, the developed countries have large proportions of elderly people, and so they have many cases of Alzheimers disease in the community at one time. However, developing countries are also undergoing a demographic transition so that more and more persons are surviving to an old age.

Purchase a copy of this report @

Global Alzheimers disease has increased manifold and expected to cross US$ 19 Billion by 2015. North America controls more than 50% of the total Alzheimers drug market share in 2010. Over the past years, the Alzheimers disease market has been flagged with several drugs into the market. Till last year Aricept was the world best selling drug which lost patent protection in November 2010, a milestone that will be followed by a rapid loss in sales. But there are other drugs which has the potential to become blockbuster drug by 2010. Namenda, Exelon has shown alluring growth in the market and become blockbusters in 2010. Ebixa a drug of Memantine group is expected to have a Billion dollar market by 2014. Given the alarming worldwide growth in Alzheimers patients, and especially if companies are able to address major unmet needs, the outlook for the Alzheimers disease market is excellent.

This report titled Alzheimers Disease Patients & Market Worldwide, Future Scenario (2010 2015) & Drugs Analysis studies the Alzheimers Disease patients prevalence worldwide and region wise. The report provides data on the Alzheimers Disease market Worldwide, North America, Europe and Rest of the world.

Complete report available @

Key Company Profiles

This section provides business overview and key financial information of the companies listed below: Forest Laboratories, Eisai, H. Lundbeck A/S, Novartis, Merz GmbH & Co. KGaA, Johnson & Johnson, UCB

Alzheimers drugs such as Exelon, Aricept, Namenda, Razadyne, Axura, Ebixa, Nootropil, Prometax, Memac, Eranz market past, present and future scenario has been analyzed in this report.

Research Highlights

  •      More than 35 Million people are expected to suffer from Alzheimers disease by 2015 worldwide.
  •     By 2050, 59 percent of the worlds Alzheimers cases will live in Asia.
  •     Global Alzheimers disease market is expected to cross the figure of US$ 19 Billion by 2015.
  •     North America is the leading market share taker in the Alzheimers disease market.
  •     Aricept sales is expected to fall after losing its patent in November 2010
  •     Ebixa, Excelon & Namenda are on the path of becoming the next blockbuster drugs after Aricept

Major points from Table of contents ( are listed below:

1. Executive Summary
2. Worldwide Prevalence of Alzheimers Patients
3. Regional Estimates for Alzheimers Patients
4. Worldwide Alzheimers Disease Market
5. Worldwide Alzheimers Drug Market Share 2008 2009
6. Worldwide Top 10 Alzheimers Drug Brands Market Performance
7. Alzheimers Disease Deals, 2005 2009
8. Key Drivers of Growth in Global Alzheimers Disease Drug Market
9. Key Challenges in the Global Alzheimers Disease Drug Market
10. Key Players in the Alzheimers Drug Market
List of Tables

Explore more reports on Pharmaceuticals Market @

About Us: is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the pharmaceuticals industry, offers research studies on agriculture, travel & hospitality, consumer goods, semiconductor and electronics, retail, environment, food and beverages, it & telecommunication, agriculture, chemicals, healthcare, chemicals, advanced materials, energy and power, medical devices and much more.

For the original version on PRWeb visit:

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WDRB. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.